2023-11-18 02:04:00
Hamburger
18 Nov. 2023 09:04 a.m.
Share news
column
Prof. Dr. Theeraphong Tantawichian, Assistant Director of Academic Affairs, Saowabha Institute, Thai Red Cross Society, talks about the COVID-19 vaccine. in the elderly that COVID-19 outbreak All over the world, it has been found that it is still an omicron species. which has decreased in severity But it spreads better than before and every time there is a mutation. will begin to be lost in fighting infection When the transmission improves, it is similar to chickenpox. Everyone will eventually be infected with COVID-19. But it will be stylish. It’s not that you get infected and die, that is, you must have immunity. Therefore, receiving the booster vaccine is important. This will help reduce the severity of the disease and hospital stay. for future protection Vaccination should be accelerated for populations who have never received the vaccine, people who have been infected but have never received the vaccine, newborns, and give booster shots to populations with risk factors for severe infection at least once a year. General people who want to reduce the risk of infection You can also receive the annual vaccine on a voluntary basis.
Dr. Weerawat Manosutti, a qualified doctor from the Department of Disease Control, said about long-acting immunization (LAAB) that the majority of patients hospitalized with COVID-19 infection are immunocompromised patients, such as those Suffering from end-stage kidney disease organ transplant patient cancer patient The patient received immunosuppressant drugs. Another group of HIV patients is the elderly and patients with 7 chronic diseases, or group 607. For the prevention of these 2 groups, it is to receive ready-made, long-acting immunity. Supplement with booster vaccinations The advantage of long-acting ready-made immune injections is that they will take effect within 6 hours, without having to wait for the body to build immunity. Currently, there are more than 200,000 doses of ready-made, long-acting immune injections. It is expected that in early 2024, the second generation of ready-made, long-acting immunity will be introduced. Which protects well and lasts longer.
divmargin:0 -15px;@media (max-width:767.98px).css-x9zhmpwidth:100vw;max-width:inherit;margin:30px -15px;]]>
1700295200
#Groups #risk #COVID19 #vaccination #readymade #longacting #immunity